Dr. Zhu's work at Emory University has been marked by significant contributions to cancer research.
ATLANTA, GA, December 02, 2024 /24-7PressRelease/ -- Lei Zhu, PhD, has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Dr. Zhu is a distinguished figure in biopharmaceuticals. Since 2018, he has been the Chief Operating Officer at MIGRA Therapeutics LLC, a company he co-founded alongside Dr. Lily Yang. The company is dedicated to the clinical translation and commercialization of innovative drug delivery approaches and novel targeted nanoparticles developed in their academic research laboratory at Emory University in Atlanta. Dr. Zhu's role at MIGRA Therapeutics LLC underscores his commitment to advancing medical science through practical applications.
In addition to his leadership at MIGRA Therapeutics, Dr. Zhu has been an Assistant Professor in the school of medicine at Emory University, division of surgical oncology, department of surgery, since 2019. His academic career at Emory began in 2015 when he joined as a postdoctoral fellow, later becoming an associate scientist from 2018 to 2019. Dr. Zhu's work at the university has been marked by significant contributions to cancer research, particularly in developing groundbreaking treatments that have shown remarkable efficacy in improving patient outcomes.
Earlier in his career, Dr. Zhu was an Associate Professor at Xiamen University in China from 2013 to 2015. His academic journey also included a postdoctoral fellowship at the National Institutes of Health between 2011 and 2013, where he honed his cell and molecular biology expertise. This period was pivotal as it laid the foundation for his future endeavors in the U.S..
Dr. Zhu's educational background includes a Bachelor of Science in Bioengineering from Jilin Agricultural University, a Master of Science in Molecular Biology and a Doctor of Philosophy in Cell Biology from Jilin University in China in 2011. His academic achievements have been instrumental in his success, providing him with a robust foundation for his research and professional pursuits.
When he is not business with work-related commitments, Dr. Zhu enjoys being an active member of academic and industry-related organizations , such as the American Association for Cancer Research (AACR) and the Discovery and Developmental Therapeutics Research Program at the Winship Cancer Institute of Emory University.
Dr. Zhu has been recognized throughout his career with several awards, including two Small Business Innovation Research (SBIR) Awards, one Small Business Technology Transfer Research (STTR) Award, and multiple Research Project Awards for Nanomedicine Development. Excited about future opportunities, Dr. Zhu remains committed to significantly contributing to cancer treatment options through ongoing laboratory work while progressing his products to clinical trials.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.
# # #